American International Group’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-17,570
| Closed | -$1.4M | – | 279 |
|
|
2024
Q1 | $1.4M | Sell |
17,570
-151
| -0.9% | -$12.1K | 0.01% | 1139 |
|
|
2023
Q4 | $1.41M | Buy |
17,721
+162
| +0.9% | +$12.9K | 0.01% | 1140 |
|
|
2023
Q3 | $1.23M | Buy |
17,559
+1,724
| +11% | +$120K | 0.01% | 1140 |
|
|
2023
Q2 | $1.14M | Buy |
15,835
+368
| +2% | +$26.4K | 0.01% | 1177 |
|
|
2023
Q1 | $954K | Buy |
15,467
+307
| +2% | +$18.9K | 0.01% | 1237 |
|
|
2022
Q4 | $1.17M | Buy |
15,160
+1,040
| +7% | +$80.2K | 0.01% | 1146 |
|
|
2022
Q3 | $630K | Buy |
14,120
+679
| +5% | +$30.3K | ﹤0.01% | 1435 |
|
|
2022
Q2 | $515K | Sell |
13,441
-354
| -3% | -$13.6K | ﹤0.01% | 1586 |
|
|
2022
Q1 | $571K | Sell |
13,795
-971
| -7% | -$40.2K | ﹤0.01% | 1650 |
|
|
2021
Q4 | $558K | Sell |
14,766
-441
| -3% | -$16.7K | ﹤0.01% | 1745 |
|
|
2021
Q3 | $501K | Sell |
15,207
-362
| -2% | -$11.9K | ﹤0.01% | 1854 |
|
|
2021
Q2 | $1.05K | Sell |
15,569
-579
| -4% | -$39 | ﹤0.01% | 1486 |
|
|
2021
Q1 | $914 | Buy |
16,148
+43
| +0.3% | +$2 | ﹤0.01% | 1508 |
|
|
2020
Q4 | $1.31K | Sell |
16,105
-462
| -3% | -$38 | ﹤0.01% | 1267 |
|
|
2020
Q3 | $1.18M | Sell |
16,567
-378
| -2% | -$26.9K | 0.01% | 1167 |
|
|
2020
Q2 | $1.39M | Buy |
16,945
+960
| +6% | +$79K | 0.01% | 1081 |
|
|
2020
Q1 | $940K | Buy |
15,985
+227
| +1% | +$13.3K | 0.01% | 1137 |
|
|
2019
Q4 | $1.63M | Sell |
15,758
-132
| -0.8% | -$13.6K | 0.01% | 1091 |
|
|
2019
Q3 | $322K | Buy |
15,890
+406
| +3% | +$8.23K | ﹤0.01% | 1900 |
|
|
2019
Q2 | $399K | Buy |
+15,484
| New | +$399K | ﹤0.01% | 1825 |
|
|
2017
Q2 | – | Sell |
-6,840
| Closed | -$27K | – | 3082 |
|
|
2017
Q1 | $27K | Buy |
6,840
+448
| +7% | +$1.77K | ﹤0.01% | 2934 |
|
|
2016
Q4 | $43K | Sell |
6,392
-17
| -0.3% | -$114 | ﹤0.01% | 2885 |
|
|
2016
Q3 | $50.5K | Buy |
6,409
+9
| +0.1% | +$71 | ﹤0.01% | 2893 |
|
|
2016
Q2 | $48.3K | Buy |
+6,400
| New | +$48.3K | ﹤0.01% | 2961 |
|